NCT01959399View on ClinicalTrials.gov

Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Healthy SubjectsPharmacokinetics of ASP015K

Interventions

DRUG

ASP015K

oral tablet

DRUG

Rosuvastatin

oral tablet

Trial Locations (1)

91206

PAREXEL - Early Phase Unit, Glendale

Sponsors

Collaborators (1)

Janssen Biotech, Inc.

All Listed Sponsors

collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01959399 - Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin | Biotech Hunter | Biotech Hunter